{"id":"allomethadione","rwe":[],"tags":[{"label":"allomethadione","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"malazol","offLabel":[],"synonyms":["aloxidone","allomethadion","allomethadione","allydione","malazol","malidone","allometadione"],"timeline":[],"brandName":"Malazol","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"allomethadione","explanation":"Imagine your body's cells are like locks, and Malazol is a key that fits into one of those locks. When it binds to the lock, it can affect how the cell works, but we don't yet know how it specifically interacts with the lock or what effects it has on the cell.","oneSentence":"Malazol is thought to work by interacting with a specific molecular target, although the exact nature of this interaction is not yet understood.","technicalDetail":"Malazol's mechanism of action is not well understood, but it is believed to involve the inhibition of a specific enzyme or receptor, leading to downstream effects on cellular function."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3666","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ALLOMETHADIONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:37:36.810803","biosimilars":[],"competitors":[],"genericName":"allomethadione","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"BFT641Z2YT","CHEBI":"CHEBI:134781","INN_ID":"993","UMLSCUI":"C2698050","ChEMBL_ID":"CHEMBL93070","PUBCHEM_CID":"10683"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Malazol, also known as allomethadione, is a small molecule drug of the allomethadione class. Its exact target and mechanism of action are unknown, and it has not been approved by the FDA for any indications. As a result, there is limited information available on its commercial status, pharmacokinetics, or safety profile. Further research is needed to fully understand the properties and potential uses of Malazol. Due to its lack of FDA approval, Malazol is not currently available as a prescription medication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}